Clinical investigators as critical determinants in pharmaceutical innovation

被引：30
|
作者：
Flowers, CR [1 ]
Melmon, KL [1 ]
机构：
[1] STANFORD UNIV, MED CTR, SCH MED, DIV CLIN PHARMACOL, STANFORD, CA 94305 USA
来源：
NATURE MEDICINE | 1997年 / 3卷 / 02期
关键词：
D O I：
10.1038/nm0297-136
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：136 / 143
页数：8
相关论文
共 50 条
  • [21] The Impact of Institutional Review Boards (IRBs) on Clinical Innovation: A Survey of Investigators and IRB Members
    Stryjewski, Tomasz P.
    Kalish, Brian T.
    Silverman, Benjamin
    Lehmann, Lisa Soleymani
    JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS, 2015, 10 (05) : 481 - 487
  • [22] Identifying critical drivers of innovation in pharmaceutical industry using TOPSIS method
    Damle, Madhavi
    Krishnamoorthy, Bala
    METHODSX, 2022, 9
  • [23] Critical innovation characteristics influencing the acceptability of a new pharmaceutical product format
    Jaakkola, Elina
    Renko, Maija
    JOURNAL OF MARKETING MANAGEMENT, 2007, 23 (3-4) : 327 - 346
  • [24] Selecting investigators for a placebo controlled clinical trial: The most critical decision point?
    Niklson, IA
    Reimitz, PE
    Sennef, C
    EUROPEAN PSYCHIATRY, 1997, 12 : S261 - S262
  • [25] Blinding of clinical investigators
    Abratt, RP
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 593 - 593
  • [26] The Role of Pharmaceutical Innovation in Clinical Practice Guidelines for Chronic Diseases
    Roach, Meaghan
    Land, Natalie
    Hernandez, Jennifer
    Rau, Reina
    Chou, Jacquelyn W.
    Hickson, Stacey S.
    Rollmann, Danielle F.
    Maclean, J. Ross
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2024, 2024
  • [27] A CHALLENGE TO CLINICAL INVESTIGATORS
    CHALMERS, TC
    GASTROENTEROLOGY, 1969, 57 (06) : 631 - &
  • [28] THE REGULATION OF CLINICAL INVESTIGATORS
    ENDRIES, RN
    FOOD AND DRUG LAW JOURNAL, 1980, 35 (07): : 415 - 423
  • [29] Clinical trials methodology: a training programme for clinical investigators and sub-investigators
    Karlberg, JPE
    Lui, WF
    ACTA PHARMACOLOGICA SINICA, 1997, 18 (06): : 552 - 556
  • [30] Guidance for Clinical Investigators, Industry, and FDA Staff Financial Disclosure by Clinical Investigators
    Guidance, Draft
    BIOTECHNOLOGY LAW REPORT, 2011, 30 (05) : 597 - 612
12345